Mitochondrial complex I activity in microglia sustains neuroinflammation

L. Peruzzotti-Jametti,C. M. Willis,G. Krzak,R. Hamel,L. Pirvan,R.-B. Ionescu,J. A. Reisz,H. A. Prag,M. E. Garcia-Segura,V. Wu,Y. Xiang,B. Barlas,A. M. Casey,A. M. R. van den Bosch,A. M. Nicaise,L. Roth,G. R. Bates,H. Huang,P. Prasad,A. E. Vincent,C. Frezza,C. Viscomi,G. Balmus,Z. Takats,J. C. Marioni,A. D’Alessandro,M. P. Murphy,I. Mohorianu,S. Pluchino

DOI: https://doi.org/10.1038/s41586-024-07167-9

IF: 64.8

2024-03-14

Nature

Abstract:Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis 1 . Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells 2 . However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Ccomplex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system 3 .

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to explore and address key issues in chronic central nervous system (CNS) inflammatory diseases, particularly the persistent low-grade inflammatory state in multiple sclerosis (MS). Specifically, the research focuses on the following points:

1. **Relationship between metabolic characteristics and inflammation persistence**: Researchers aim to understand how different metabolic characteristics influence the functional state of myeloid cells (including microglia) and investigate how these metabolic characteristics maintain the inflammatory state of the central nervous system.

2. **Mechanism of action of mitochondrial complex I**: Through multi-omics approaches, researchers found that mitochondrial complex I activity drives reverse electron transport (RET), thereby producing reactive oxygen species (ROS). Further research indicates that inhibiting mitochondrial complex I can protect the central nervous system from neurotoxic damage and improve functional outcomes in animal models.

3. **Potential therapeutic targets**: The study reveals that mitochondrial complex I activity in microglia may become a potential therapeutic target for treating chronic inflammatory central nervous system diseases to promote neuroprotection.

In summary, this paper attempts to provide a theoretical basis for developing new therapeutic strategies in the future by deeply analyzing the metabolic mechanisms of microglia in chronic inflammatory diseases and their impact on neural damage.